Phase II trial of atezolizumab in BCG-unresponsive non-muscle invasive bladder cancer: SWOG S1605 (NCT #02844816).Peter C. Black, Ian M. Thompson, Parminder Singh et al.|Journal of Clinical Oncology|2020Cited by 55